✦ LIBER ✦

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

✍ Scribed by Armstrong, Deborah K.; Bundy, Brian; Wenzel, Lari; Huang, Helen Q.; Baergen, Rebecca; Lele, Shashikant; Copeland, Larry J.; Walker, Joan L.; Burger, Robert A.

Book ID: 121496500
Publisher: Massachusetts Medical Society
Year: 2006
Tongue: English
Weight: 751 KB
Volume: 354
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa052985

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal cisplatin therapy in ova

Intraperitoneal cisplatin therapy in ovarian cancer: Comparison with standard intravenous carboplatin and paclitaxel

✍ Robert F. Ozols; Michael A. Bookman; Andreas du Bois; Jacobus Pfisterer; Alexand 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Intraperitoneal Cisplatin and Intravenou

Intraperitoneal Cisplatin and Intravenous Paclitaxel in the Treatment of Epithelial Ovarian Cancer Patients with a Positive Second Look

✍ S. Makhija; P. Sabbatini; C. Aghajanian; E. Venkatraman; D.R. Spriggs; R. Baraka 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Combination chemotherapy with paclitaxel

Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm

✍ F. Terauchi; T. Moritake; Y. Yamamoto; H. Ogura 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 659 KB

Phase II trial of intraperitoneal cispla

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

✍ Lisa M. Landrum; Johnny Hyde Jr.; Robert S. Mannel; D. Scott McMeekin; Kathleen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

BRCA1 expression and improved survival i

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study

✍ Lesnock, J L; Darcy, K M; Tian, C; DeLoia, J A; Thrall, M M; Zahn, C; Armstrong, 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 451 KB

Progression-free and overall survival of

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer

✍ Joyce N. Barlin; Fanny Dao; Nadim Bou Zgheib; Sarah E. Ferguson; Paul J. Sabbati 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB